Published: Jun 5, 2026
Written by Klarity Editorial Team
Published: Jun 5, 2026

Finding the right mental health care can feel overwhelming—especially when you’re navigating the crowded world of telehealth providers. If you’re searching for online therapy, psychiatry, or help with conditions like ADHD, anxiety, or depression, you’ve probably seen names like Cerebral, Talkiatry, Brightside, and Teladoc pop up. But which one is right for you? And more importantly, which ones can you trust?
The telehealth mental health landscape has changed dramatically since the pandemic boom of 2020–2021. Some once-promising startups have shut down or faced legal trouble, while others have tightened their prescribing policies under regulatory scrutiny. At the same time, established players have expanded their offerings, and new niche providers have emerged to fill specific gaps in care.
This comprehensive guide breaks down the current state of online mental health providers in late 2025, comparing the major platforms on availability, services offered, medication policies, pricing, and quality of care. Whether you’re looking for ADHD treatment, anxiety medication, therapy, or something else entirely, we’ll help you understand your options—and where providers like Klarity Health fit into the picture.
The COVID-19 pandemic accelerated telehealth adoption by an estimated 5–10 years, with mental health services leading the charge. Virtual psychiatry and therapy apps promised convenient, affordable care for millions of Americans who previously struggled with access. For a while, it seemed like a win-win: patients got faster appointments, and startups attracted massive investment.
But 2022–2024 brought a sobering correction. Regulatory agencies—particularly the DEA and DOJ—began investigating companies that appeared to prescribe controlled substances too liberally. Several high-profile platforms faced consequences:
These developments have fundamentally reshaped how telehealth companies approach mental health care—particularly when it comes to controlled medications like stimulants, benzodiazepines, and sleep aids.
Stricter Prescribing Standards: Most direct-to-consumer telehealth platforms now avoid prescribing Schedule II stimulants (Adderall, Ritalin) and benzodiazepines (Xanax, Ativan) altogether. Even providers that still prescribe these medications have implemented more rigorous evaluation processes.
Greater Emphasis on Quality: The ‘pill mill’ perception has made both regulators and patients more skeptical. Surviving companies have had to demonstrate that they’re providing legitimate psychiatric care, not just rubber-stamping prescriptions.
Pricing Transparency: As competition intensified, patients began demanding clearer pricing models. Subscription-based services face criticism for being inflexible and hard to cancel, while à la carte models (like Klarity Health’s approach) have gained traction.
Insurance Integration: More platforms now work with insurance companies to reduce out-of-pocket costs—though this can sometimes mean longer wait times and less flexibility.
To help you navigate your options, we’ve compiled detailed information on the leading platforms. Below, you’ll find side-by-side comparisons covering operating status, services offered, medication policies, geographic availability, pricing, and insurance acceptance.
| Provider | Status | Primary Focus | Prescribes Stimulants? | Prescribes Benzos? | States Served | Starting Price |
|---|---|---|---|---|---|---|
| Cerebral | Limited operations | Depression, anxiety, insomnia | No (stopped 2022) | No | 50 | $99/month |
| Done | Effectively inactive | ADHD | Yes (historically) | No | 0 (shut down) | N/A |
| Brightside | Active | Depression, anxiety, PTSD | No | No | 50 | $95/month |
| Talkiatry | Active | Full psychiatric care | Yes (when appropriate) | Yes (when appropriate) | 43 | $25–$400/visit |
| PlushCare | Active | Primary care + mental health | No | No | 50 | $19.99/month + $129/visit |
| MDLive | Active | Urgent care + therapy | No | No | 50 | $0–$82/visit |
| Teladoc | Active | General telehealth + mental health | No | No | 50 | $75–$95/visit |
| Amwell | Active | Urgent care + psychiatry | No | No | 50 | $79–$99/visit |
| Hims/Hers | Active | Lifestyle wellness + mental health | No | No | 50 | $85/month |
| Klarity Health | Active | Specialized psychiatric care | Yes (when appropriate) | Yes (when appropriate) | Multiple states | $149 initial, $59 follow-up |
What Happened: Cerebral exploded during the pandemic, offering monthly subscriptions for therapy and medication management. At its peak in 2021, it served over 100,000 patients. However, internal complaints about pressure to prescribe stimulants and an investigation by the DEA led to major changes. In May 2022, Cerebral stopped accepting new patients seeking ADHD stimulant prescriptions, and by November 2024, the company settled with federal authorities for $3.6 million.
Current Services: Cerebral still operates but has pivoted to a more conservative prescribing approach. They now focus on depression, anxiety, insomnia, and other conditions that can be managed with non-controlled medications like SSRIs and SNRIs.
Medication Policy:
Pricing: Medication management costs $99/month; combined therapy and medication management runs $365/month after an initial promotional rate.
Insurance: Limited insurance acceptance; most patients pay out-of-pocket.
Bottom Line: Cerebral can work for straightforward depression or anxiety, especially if you prefer a subscription model. However, if you need ADHD medication or have complex psychiatric needs, you’ll need to look elsewhere.
What Happened: Done Health focused exclusively on adult ADHD, promising 15-minute evaluations and same-day prescriptions. The model proved popular but controversial. In June 2024, federal prosecutors indicted Done’s CEO and president, alleging they prescribed over 40 million stimulant pills to patients nationwide with inadequate medical oversight. The company effectively ceased operations, leaving thousands of patients scrambling for alternative care.
Current Status: Done’s website remains live, but new patient enrollment appears frozen, and existing patients have reported difficulty accessing care.
Key Takeaway: Done’s collapse highlights the dangers of prioritizing convenience over clinical rigor. It’s a reminder to patients: if a provider promises instant ADHD medication without thorough evaluation, that’s a red flag.
Who They Serve: Brightside focuses on depression, anxiety, PTSD, OCD, and insomnia—but explicitly does not treat ADHD or prescribe controlled substances.
Medication Policy:
Pricing: $95/month for medication management only, or $349/month for combined therapy and medication management.
Insurance: Brightside accepts many major insurance plans nationwide, which can significantly reduce costs.
Who Should Consider Brightside: If you’re dealing with depression or anxiety and prefer to avoid controlled substances, Brightside offers a structured, evidence-based approach. Their emphasis on medication adherence and regular check-ins appeals to patients who want consistent support.
Who Should Look Elsewhere: Anyone seeking ADHD diagnosis/treatment or needing benzodiazepines for severe anxiety. Brightside’s narrow medication formulary is a strength for some but a limitation for others.
What Sets Them Apart: Talkiatry employs board-certified psychiatrists who can diagnose and treat the full spectrum of mental health conditions—including those requiring controlled medications.
Medication Policy:
Availability: Talkiatry operates in 43 states and recently expanded to offer adolescent psychiatry services in 31 states.
Pricing: With insurance, typical co-pays range from $25–$50 per visit. Without insurance, initial psychiatric evaluations cost around $250–$300, with follow-ups at $150.
Insurance: Talkiatry is in-network with most major insurance plans, making it one of the more affordable options for insured patients.
Pros:
Cons:
Who Should Consider Talkiatry: If you have decent insurance coverage and need comprehensive psychiatric care—including potential controlled medications—Talkiatry offers excellent value. It’s particularly suitable for complex cases requiring specialist expertise.
The Hybrid Model: PlushCare started as a primary care telehealth service and later added mental health offerings. This makes them unique—you can see the same platform for a sinus infection and a depression screening.
Medication Policy:
Pricing: $19.99/month membership fee plus $129 per visit. This à la carte structure means you only pay when you actually see a provider.
Insurance: Accepts most major insurance plans, which can cover visit costs beyond the membership fee.
Who Should Consider PlushCare: If you want one platform for both physical and mental health needs, PlushCare offers convenience. It’s also a good fit for mild to moderate depression or anxiety that doesn’t require controlled medications.
Limitations: Not suitable for ADHD treatment or complex psychiatric conditions. The primary care providers on PlushCare have limited mental health training compared to psychiatrists.
These three platforms dominate the general telehealth space, often offered as employee benefits or insurance add-ons.
Common Features:
Medication Restrictions (applies to all three):
Pricing Without Insurance:
Who Should Use These Platforms: They’re excellent for general healthcare needs, minor mental health concerns (like starting an SSRI), or if your insurance covers them at no cost. However, they’re not suitable for ADHD treatment or conditions requiring controlled medications.
The Different Angle: Hims & Hers (and their associated platform Ro) began with hair loss and erectile dysfunction treatments, then expanded into mental health, skin care, and weight management.
Mental Health Services:
Notable Addition: Hims & Hers made headlines by offering GLP-1 weight loss medications (Wegovy/Ozempic), capitalizing on the obesity treatment boom. They can also prescribe non-controlled testosterone replacement for men.
Who They Appeal To: Younger adults (typically 25–45) seeking convenient, stigma-free treatment for common conditions. The modern branding and app-based model resonate with tech-savvy patients.
Limitations:
One of the most important factors in choosing a telehealth mental health provider is understanding what medications they can and will prescribe. Let’s break down the key drug categories:
Examples: Adderall (amphetamine salts), Ritalin (methylphenidate), Vyvanse (lisdexamfetamine), Concerta
Current State in Telehealth: Most direct-to-consumer platforms have stopped prescribing these medications due to regulatory scrutiny. The notable exceptions are:
Why the Restrictions: Schedule II substances have high potential for abuse and diversion. The DEA scrutinized several telehealth companies for allegedly prescribing stimulants without adequate safeguards, leading most platforms to simply avoid them.
What This Means for Patients: If you genuinely need ADHD medication, you’ll need to work with a specialized psychiatric telehealth provider or traditional in-person psychiatry. The upside is that providers who do prescribe stimulants now tend to offer more thorough evaluations.
Examples: Xanax (alprazolam), Ativan (lorazepam), Klonopin (clonazepam), Valium (diazepam)
Current State: Even more restricted than stimulants in telehealth settings. Almost no direct-to-consumer platforms prescribe benzos due to:
Platforms That May Prescribe:
The Clinical Perspective: Modern psychiatric practice generally views benzodiazepines as short-term solutions only. For chronic anxiety, providers prefer SSRIs, SNRIs, buspirone, or therapy-based approaches. That said, there are cases where benzos remain the best option—such as severe panic disorder unresponsive to other treatments.
Z-Drugs (Ambien/zolpidem, Lunesta/eszopiclone, Sonata/zaleplon) are Schedule IV controlled substances that virtually no telehealth platform will prescribe remotely.
Alternative Approaches:
Most telehealth providers focus on these alternatives first, which align with current clinical guidelines recommending against long-term use of Z-drugs.
This is the newest frontier in telehealth. GLP-1 agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) have revolutionized obesity treatment.
Who Prescribes Them:
Who Doesn’t:
Important Note: The FDA issued warnings in September 2025 about telehealth companies marketing ‘compounded’ versions of these drugs, which some platforms offered due to brand-name shortages. Always verify you’re getting FDA-approved medications.
Now that you understand the broader telehealth mental health ecosystem, where does Klarity Health fit in—and why might it be the right choice for you?
Klarity Health occupies a unique middle ground in the market:
Like Talkiatry: Klarity offers comprehensive psychiatric care from licensed providers who can prescribe controlled medications when clinically appropriate. This includes ADHD stimulants and anxiety medications that most direct-to-consumer platforms avoid.
Unlike Talkiatry: Klarity doesn’t require insurance and operates on transparent, flat-rate pricing. You don’t need to navigate pre-authorization or worry about unexpected bills.
Like Brightside/Cerebral: Klarity uses a modern, user-friendly digital platform that makes scheduling and follow-up care convenient.
Unlike Brightside/Cerebral: Klarity doesn’t lock you into monthly subscriptions or restrict medication options to non-controlled substances only.
1. Comprehensive Prescribing with Appropriate Safeguards
Klarity learned from the mistakes of Done and early Cerebral. The platform:
Result: You can access necessary medications—including ADHD stimulants or anxiety medications—without the ‘pill mill’ red flags that plagued other services.
2. Transparent, Flexible Pricing
Klarity’s structure is straightforward:
Why This Matters: Compare this to Cerebral ($99–$365/month whether you need a visit or not) or Brightside ($95–$349/month). With Klarity, you might pay $208 total for your initial visit plus one follow-up, versus $198–$698 for two months of a subscription service—and Klarity providers can prescribe medications those platforms can’t.
3. Insurance and Cash Pay Options
Klarity accepts both insurance and self-pay patients. If you have insurance, they’ll work to get coverage for your visits. If you’re uninsured or prefer not to use insurance (to maintain privacy or avoid deductibles), the cash prices are competitive.
This flexibility matters in 2025, where high-deductible health plans have become common. Many people technically have insurance but pay out-of-pocket until they hit $3,000+ deductibles—making Klarity’s transparent pricing actually more affordable than ‘in-network’ services for these patients.
4. Conditions Treated
Klarity addresses several needs that other platforms exclude or handle poorly:
This broader scope means you might not need multiple platforms. Compare this to needing Brightside for depression but Talkiatry for ADHD, or using Hims for one condition and a separate provider for another.
5. Provider Availability and Speed
One common complaint about insurance-based telepsychiatry services like Talkiatry is wait times—sometimes 2–4 weeks for an initial appointment in high-demand states. Klarity typically offers appointments within days, not weeks.
For someone experiencing acute symptoms or who has just run out of medication, this speed difference is crucial.
You’re an Ideal Klarity Patient If:
Klarity Might Not Be the Best Fit If:
For readers in major states, here’s a quick reference on provider availability:
Available: Cerebral, Brightside, Talkiatry, PlushCare, MDLive, Teladoc, Amwell, Hims/Hers, Klarity Health
Not Operating: Done (shut down), Ahead (shut down)
Notable: California has strict telehealth regulations, which actually weeded out lower-quality providers early. The platforms operating in CA tend to be more established and compliant.
Available: All major platforms listed above
Special Consideration: Texas has specific rules about initial appointments for controlled substances—some require an in-person component or video visit with specific protocols. Reputable providers handle this compliance.
Available: All major platforms
Growth Area: Florida has seen significant telehealth expansion due to its large population, high demand for mental health services, and relatively friendly regulatory environment.
Available: All major platforms (though Talkiatry has especially strong presence here)
Regulatory Note: NY was slower to adopt telehealth flexibilities but has caught up post-pandemic. Insurance coverage for telehealth is strong in NY.
Available: All major platforms
Insurance Coverage: Both states have good parity laws requiring insurance to cover telehealth similarly to in-person care, which benefits platforms like Talkiatry and MDLive.
Before choosing a telehealth mental health provider, consider these questions:
If yes, your options narrow significantly. Platforms willing to prescribe stimulants or benzodiazepines when appropriate:
Good insurance with mental health coverage: Talkiatry or insurance-partnered services like MDLive
High-deductible plan or uninsured: Klarity’s transparent cash pricing may cost less than hitting your deductible with insurance-based services
Insurance but prefer privacy: Cash-pay options (Klarity, Hims/Hers) keep mental health care off insurance records
Urgent (within days): Klarity, general telehealth platforms for basic issues
Standard (1–2 weeks okay): Most platforms
Non-urgent: Any option works
Medication management only: Klarity, Brightside (for non-controlled), Cerebral
Therapy only: BetterHelp, Talkspace (not covered in this guide, but worth noting)
Both: Talkiatry, Cerebral, or combining services (e.g., Klarity for meds + separate therapist)
The Done and Cerebral controversies highlighted practices to avoid. Watch out for:
🚩 Guaranteed Prescriptions: Any provider promising you’ll definitely get ADHD medication or other controlled substances before evaluation
🚩 Extremely Brief Evaluations: 10–15 minute ‘assessments’ for complex conditions like ADHD or anxiety disorders
🚩 Pressure to Start Medications: Good providers discuss all options (therapy, lifestyle changes, medication) without pushing pills
🚩 Difficulty Canceling: Subscription services that make it hard to pause or stop should raise concerns
🚩 Lack of Follow-Up: Responsible prescribing of controlled substances requires regular check-ins—not just automatic refills
🚩 Unclear Pricing: If you can’t find straightforward cost information, be cautious
🚩 Provider Turnover: Constantly changing providers disrupts continuity of care and may indicate internal problems
As we move into 2026, several trends are shaping the industry:
The DEA’s COVID-era flexibilities for prescribing controlled substances via telehealth were extended through December 2025, but the future remains uncertain. Providers are preparing for potential scenarios:
Best case: Telehealth flexibilities become permanent with added safeguards
Middle ground: Hybrid model requiring initial in-person visit before telehealth prescribing
Restrictive scenario: Return to pre-COVID rules limiting controlled substance prescribing
Smart platforms like Klarity are building flexibility into their models—including partnerships or protocols for in-person components if needed.
Expect more collaboration between mental health telehealth and primary care. Your online psychiatrist and regular doctor might soon share records more seamlessly, improving coordination.
The line between mental health and general wellness continues to blur:
Platforms offering integrated care for these interconnected issues (like Klarity’s inclusion of insomnia, PMDD, and binge eating disorder) align with where medicine is headed.
While human providers remain essential, expect AI tools to help with:
The best providers will use technology to enhance—not replace—human clinical judgment.
Based on everything covered, here’s a decision framework:
Best options: Klarity Health or Talkiatry
Why: They can provide proper evaluation and prescribe stimulants if appropriate. Start with Klarity if you want faster appointments and transparent cash pricing; choose Talkiatry if you have excellent insurance and don’t mind potential wait times.
Avoid: Cerebral (stopped ADHD stimulants), Brightside (doesn’t treat ADHD), general telehealth platforms
Best options: Brightside, Cerebral, or Klarity for medication management + consider adding a therapist
Why: All three can start you on non-controlled antidepressants and provide regular monitoring. Brightside’s conservative approach might be most comfortable for medication-hesitant patients.
Klarity advantage: If you discover you need more comprehensive treatment later (e.g., adding ADHD medication), you won’t need to switch platforms.
Best options: Klarity Health (if paying cash) or Talkiatry (if using insurance)
Why: You need a provider who can prescribe controlled substances. Both offer legitimate ongoing management.
Avoid: Platforms that don’t prescribe stimulants at all
Best options: Use your insurance’s telehealth benefit (often MDLive, Teladoc, or Amwell at no cost)
Why: If your insurance covers these services at $0 copay and you only need basic medication like an SSRI, why pay more?
Consider upgrading to Klarity or Talkiatry if: Your condition is more complex than initially thought, or free services have long wait times.
Best options: Klarity Health, Hims/Hers, or cash-pay services
Why: Paying out-of-pocket means no insurance claims, no pre-authorization, no record of mental health treatment on your insurance history.
Klarity advantage: Comprehensive psychiatric care at transparent prices; HSA/FSA eligible
The telehealth mental health landscape in 2025–2026 offers more options than ever—but also requires more discernment. The wild-west days of easy prescriptions are over, which is ultimately good for patient safety even if it means fewer shortcuts.
Key Takeaways:
Klarity Health positions itself as a solution to common frustrations: too-strict policies that limit necessary medications (like many platforms), overly aggressive prescribing (like Done), confusing subscription models (like Cerebral), or insurance bureaucracy (like some Talkiatry experiences). By offering comprehensive psychiatric care with transparent pricing and appropriate prescribing, Klarity aims to fill the gap between ‘won’t prescribe anything controlled’ and ‘will prescribe too readily.’
Whether you choose Klarity or another provider, the most important step is simply getting started. Mental health treatment works—but only when you access it. If you’ve been putting off seeking help because the options seemed overwhelming, we hope this guide has clarified your path forward.
If Klarity sounds like the right fit for your needs, getting started is straightforward:
Klarity’s combination of specialized psychiatric expertise, medication access when clinically appropriate, flexible pricing, and responsive support makes it a strong choice for adults seeking comprehensive mental health care in 2025 and beyond.
Don’t let the confusion of choosing between dozens of platforms delay your care. Whether you move forward with Klarity, another specialized service, or your insurance’s telehealth benefit, the best provider is the one that matches your specific needs—and that you’ll actually use.
Your mental health matters. The right support is available. And now you have the information to make an informed choice.
Associated Press. ‘Top executives of California-based telehealth company Done indicted for ADHD drug distribution.’ AP News, June 14, 2024. https://apnews.com/article/498cb907623565ee680b33b1367efb84
Hao, Karen. ‘Why Online Therapy Startups Are Falling Short on Their Promises.’ TIME Magazine, November 1, 2022. https://time.com/6225361/telehealth-startups-cerebral-done-ahead/
Landi, Heather. ‘Pushing ADHD telehealth presc
Find the right provider for your needs — select your state to find expert care near you.